{"id":204404,"date":"2025-01-23T22:32:23","date_gmt":"2025-01-24T04:32:23","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/01\/fundraising-for-founder-led-biotech"},"modified":"2025-01-23T22:32:23","modified_gmt":"2025-01-24T04:32:23","slug":"fundraising-for-founder-led-biotech","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/01\/fundraising-for-founder-led-biotech","title":{"rendered":"Fundraising for Founder-led Biotech"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/fundraising-for-founder-led-biotech3.jpg\"><\/a><\/p>\n<p>A blog webpage written by entrepreneur Matt Krisiloff which offers helpful advice to scientific founders of biotechnology companies on how to fundraise and manage relations with investors.<\/p>\n<p>\u201cBecause of examples of great success in the broader technology world, we\u2019re seeing the emergence of what I\u2019d call a more \u2018Silicon Valley\u2019 mindset in biotech investing. This approach prizes technology development at the core of the company\u2019s DNA and \u2013 drawing from examples in tech such as Microsoft and Meta and in biotech such as Regeneron and Genentech \u2013 recognizes that technical founders who can grow into business leaders often build more innovative and ultimately more successful companies. This shift has opened up new avenues for fundraising that founders should understand and look towards\u201d<\/p>\n<p>[](<a href=\"https:\/\/mattkrisiloff.com\/2025\/01\/07\/fundraising-for-found-led-biotech\/\">https:\/\/mattkrisiloff.com\/2025\/01\/07\/fundraising-for-found-led-biotech\/<\/a>) <\/p>\n<hr>\n<p>At this point in my career across the biotech-related projects I\u2019ve run, I\u2019ve personally raised about $100 million. In some ways this feels like a lot, but given the scope of biotech and hard tech projects I care most about, it\u2019s really just a drop in the bucket. From these experiences though, I\u2019ve learned some things that I believe can help other founders navigate fundraising, and want to share them \u2013 especially for newer founders working on interesting technologies that may be approaching fundraising for the first time.<\/p>\n<p>Most of what I am saying is for biotech, but I think a lot of the observations apply for medical devices and other hard science startup fundraising too.<\/p>\n<p>Biotech exists in a unique corner of the investment world, one where the promise of revolutionary breakthroughs meets harsh realities of extended development timelines and significant capital requirements. This is truer today than ever \u2013 while the broader equity markets has seen unprecedented growth over the past two years, the biotech sector has remained in a relatively depressed state.<\/p>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2025\/01\/fundraising-for-founder-led-biotech\">Continue reading \u201cFundraising for Founder-led Biotech\u201d | &gt;<\/a><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A blog webpage written by entrepreneur Matt Krisiloff which offers helpful advice to scientific founders of biotechnology companies on how to fundraise and manage relations with investors. \u201cBecause of examples of great success in the broader technology world, we\u2019re seeing the emergence of what I\u2019d call a more \u2018Silicon Valley\u2019 mindset in biotech investing. This [\u2026]<\/p>\n","protected":false},"author":636,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,43],"tags":[],"class_list":["post-204404","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-business"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/204404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/636"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=204404"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/204404\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=204404"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=204404"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=204404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}